Slingshot members are tracking this event:
FDA Places Hold on Teva (TEVA) and Regeneron's (REGN) Phase 2b Trial Evaluating Fasinumab in Chronic Low Back Pain
Slingshot Insights Explained
Oct 17, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Clinical Hold, Fda, Phase 2b Centaur, Fasinumab, Chronic Low Back Pain